| P50 | author | Eui-Cheol Shin | Q79235655 |
| P2093 | author name string | Pil Soo Sung | |
| | Su-Hyung Park | |
| P2860 | cites work | Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion | Q24293039 |
| | A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus | Q24307721 |
| | IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage | Q24337202 |
| | Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 |
| | A diverse range of gene products are effectors of the type I interferon antiviral response | Q24626018 |
| | HBV pathogenesis in animal models: recent advances on the role of platelets | Q24672103 |
| | Regulation of hepatic innate immunity by hepatitis C virus | Q26824743 |
| | Immune responses to HCV and other hepatitis viruses | Q26866955 |
| | T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. | Q27469830 |
| | Stealth and cunning: hepatitis B and hepatitis C viruses | Q27470232 |
| | Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease | Q27473001 |
| | Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 |
| | Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees | Q27473402 |
| | Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection | Q27477499 |
| | Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor | Q27478302 |
| | Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression | Q27478366 |
| | Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction | Q27481027 |
| | Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection | Q27485119 |
| | Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man | Q27485215 |
| | Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections | Q36073739 |
| | Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. | Q36131706 |
| | Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance | Q36190873 |
| | Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity | Q36279154 |
| | Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus | Q36279345 |
| | Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity | Q36343260 |
| | The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis | Q36364632 |
| | The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection | Q36368397 |
| | Hepatitis A virus: from discovery to vaccines | Q36382222 |
| | Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses | Q36407362 |
| | Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. | Q36547702 |
| | Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. | Q36614504 |
| | Flying under the radar: the immunobiology of hepatitis C. | Q36635544 |
| | The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection. | Q36760218 |
| | A pathogenic picornavirus acquires an envelope by hijacking cellular membranes | Q36781367 |
| | Persistent LCMV infection is controlled by blockade of type I interferon signaling | Q36808119 |
| | Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection | Q36944828 |
| | Immunobiology and pathogenesis of viral hepatitis | Q37014739 |
| | Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). | Q37173264 |
| | Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells | Q37333944 |
| | Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses | Q37352688 |
| | The size of the viral inoculum contributes to the outcome of hepatitis B virus infection | Q37356013 |
| | Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors | Q37625429 |
| | Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment | Q37673234 |
| | Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver | Q37684887 |
| | Living in the liver: hepatic infections | Q37987860 |
| | The impact of differential antiviral immunity in children and adults | Q38037339 |
| | Current progress in development of hepatitis C virus vaccines | Q38120201 |
| | Induction and suppression of innate antiviral responses by picornaviruses | Q38236277 |
| | Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes | Q38926063 |
| | Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B. | Q38964920 |
| | The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis | Q38979208 |
| | An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients. | Q39037936 |
| | Melanoma Differentiation–Associated Gene 5 Senses Hepatitis B Virus and Activates Innate Immune Signaling To Suppress Virus Replication | Q39113612 |
| | Hepatitis B Virus Polymerase Impairs Interferon-α–Induced STA Activation Through Inhibition of Importin-α5 and Protein Kinase C-δ | Q39274712 |
| | Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. | Q39329221 |
| | Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade | Q27487939 |
| | Hepatitis C Virus E2 Envelope Glycoprotein Core Structure | Q27680704 |
| | Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 |
| | Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection | Q28131757 |
| | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 |
| | Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF | Q29547901 |
| | IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 |
| | Immunology of hepatitis B virus and hepatitis C virus infection | Q29618957 |
| | Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 |
| | Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 |
| | HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 |
| | Update on hepatitis E virology: Implications for clinical practice | Q30251804 |
| | Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1. | Q30277650 |
| | Hepatitis C virus promotes t-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes | Q30414014 |
| | Myeloid Suppressor Cells Induced by Hepatitis C Virus Suppress T-Cell Responses Through the Production of Reactive Oxygen Species | Q30422587 |
| | Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response | Q33597579 |
| | Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation | Q33604835 |
| | Genomic analysis of the host response to hepatitis B virus infection | Q33696514 |
| | Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses | Q33707246 |
| | CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection. | Q33718778 |
| | Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection | Q33781003 |
| | Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner | Q33822643 |
| | Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells | Q33916693 |
| | Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness | Q33922537 |
| | Pathogenesis of hepatitis B virus infection | Q33925491 |
| | Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection | Q33929089 |
| | Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus | Q33955998 |
| | Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. | Q34022995 |
| | Hepatitis C Virus Reveals a Novel Early Control in Acute Immune Response | Q34055291 |
| | Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon | Q34059504 |
| | T-Cell Dysfunction and Inhibitory Receptors in Hepatitis C Virus Infection | Q34127437 |
| | TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence | Q34205905 |
| | Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction | Q34230513 |
| | HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection. | Q34250323 |
| | Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses | Q34258994 |
| | Binding of Hepatitis A Virus to Its Cellular Receptor 1 Inhibits T-Regulatory Cell Functions in Humans | Q39376854 |
| | The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein | Q39691872 |
| | Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system | Q39756691 |
| | Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection | Q39819888 |
| | Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model | Q39888672 |
| | Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection | Q40209074 |
| | Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells. | Q40844750 |
| | Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections | Q40903773 |
| | Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. | Q40976544 |
| | Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A. | Q41290555 |
| | Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure. | Q41462634 |
| | The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus | Q41564761 |
| | A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory | Q41672361 |
| | Blockade of chronic type I interferon signaling to control persistent LCMV infection | Q41807293 |
| | PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. | Q42017650 |
| | T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee | Q42061089 |
| | A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. | Q42199452 |
| | Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation | Q42206594 |
| | Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis | Q42206865 |
| | Restoration of HCV-specific CD8+ T cell function by interferon-free therapy | Q42211746 |
| | Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection | Q42281089 |
| | Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection | Q42284303 |
| | Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection | Q42797242 |
| | Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. | Q42836169 |
| | Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. | Q42979699 |
| | Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. | Q42983710 |
| | HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 |
| | FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. | Q42989299 |
| | Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis | Q42994516 |
| | A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees | Q42998134 |
| | Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. | Q43035496 |
| | Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity | Q43036305 |
| | Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C | Q43036898 |
| | Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies | Q43041465 |
| | Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection | Q43047846 |
| | Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge | Q43048336 |
| | An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. | Q43636357 |
| | Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections | Q43713361 |
| | Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. | Q44447870 |
| | Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. | Q45368507 |
| | Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection | Q45368686 |
| | The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function | Q45371390 |
| | Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection | Q45375236 |
| | Temporal analysis of early immune responses in patients with acute hepatitis B virus infection | Q45382916 |
| | Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. | Q50558076 |
| | Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection | Q50579007 |
| | Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection | Q52563861 |
| | Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection | Q56951258 |
| | Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues | Q58802756 |
| | Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B | Q58802765 |
| | Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users | Q59200459 |
| | Increased Th17 cells contribute to disease progression in patients with HBV‐associated liver cirrhosis | Q84096204 |
| | Hepatitis B virus infection | Q88131866 |
| | Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro | Q34259130 |
| | IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection | Q34282251 |
| | Activation of natural killer cells during acute infection with hepatitis C virus. | Q34283615 |
| | Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity | Q34364103 |
| | Interferon-stimulated genes: a complex web of host defenses | Q34405609 |
| | Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. | Q34462234 |
| | CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection | Q34462354 |
| | The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development. | Q34481429 |
| | Natural Killer Cells in Viral Hepatitis | Q34505690 |
| | IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. | Q34627115 |
| | The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells | Q34629141 |
| | CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion | Q34657312 |
| | A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection | Q34744674 |
| | Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. | Q34789276 |
| | Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation | Q35002436 |
| | Broadly neutralizing antibodies abrogate established hepatitis C virus infection | Q35032263 |
| | Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. | Q35091008 |
| | Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways | Q35115583 |
| | Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus | Q35197999 |
| | Human pDCs preferentially sense enveloped hepatitis A virions | Q35242599 |
| | A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus | Q35420938 |
| | Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus | Q35465926 |
| | Cross-genotype immunity to hepatitis C virus | Q35543288 |
| | Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence | Q35679577 |
| | Reassessing immune control of hepatitis A virus | Q35685377 |
| | Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. | Q35690250 |
| | Activation of chemokine and inflammatory cytokine response in hepatitis C virus–infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates | Q35737678 |
| | Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion | Q35741969 |
| | CD39 Expression Identifies Terminally Exhausted CD8+ T Cells | Q35814795 |
| | Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus | Q35847364 |
| | Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. | Q35964140 |
| | Neutralizing antibody response during acute and chronic hepatitis C virus infection | Q35971609 |
| | Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C | Q35986301 |
| | Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. | Q35989977 |
| P433 | issue | 8 | |
| P304 | page(s) | 509-523 | |
| P577 | publication date | 2016-07-04 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Nature Reviews Immunology | Q43355 |
| P1476 | title | Immune responses and immunopathology in acute and chronic viral hepatitis | |
| P478 | volume | 16 | |